DaVita is a leading kidney care provider in the United States, delivering dialysis services to patients with end-stage renal disease across its own dialysis centers, patients' homes, hospitals, and skilled nursing facilities. The company also serves patients across earlier chronic kidney disease stages and supports kidney transplantation. Its U.S. dialysis and related lab services business constitutes its core operations.
The company has operated as a kidney care provider for more than 25 years. DaVita's care model emphasizes preventive, integrated care targeting improved outcomes and lower total costs across the chronic kidney disease continuum. Services are provided to patients regardless of location or insurance status, with treatment modalities selected to reflect individual patient needs.
USDialysis And Related Lab Services 86% · All Other Segments 14%
business segments · FY2025 (ended Dec 2025) · share of tagged segment revenue (10-K XBRL, as filed)
